article thumbnail

Luxury powerhouses turn to M&A amid slowing sales

JD Supra: Mergers

Declining consumer spending power is driving down revenues and pushing luxury firms to seek new avenues for growth - Slowing economic growth, hampered by stubborn inflation, has inhibited consumer confidence across the globe.

M&A 201
article thumbnail

M&A Strategy Update: Union Contracts and Section 363 Sales

JD Supra: Mergers

In the right situations, the United States Bankruptcy Code provides powerful tools for acquiring distressed companies and realizing economic value, including synergies from vertically integrating suppliers or customers, or purchasing competitors’ assets at a discount. By: Warner Norcross + Judd

M&A 171
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Current State of the Veterinary Industry: Independent Practice Sales to Corporate Consolidators

JD Supra: Mergers

Independent veterinary practices have increasingly been sold to corporate consolidators, a trend driven by various economic, operational, and market factors. Over the past few years, significant shifts have occurred within the veterinary field, especially when it comes to veterinary practice ownership. By: Mandelbaum Barrett PC

article thumbnail

Corporate Insights: Disclosing PHI Upon the Sale of a Medical Practice

JD Supra: Mergers

The Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, “HIPAA”) states that, absent patient authorization, a patient’s Protected Health Information (“PHI”) may not be disclosed to another Covered Entity (as defined by HIPAA) without a direct (..)

Medical 177
article thumbnail

How to Package and Price Embedded Analytics

Just by embedding analytics, application owners can charge 24% more for their product. How much value could you add? This framework explains how application enhancements can extend your product offerings. Brought to you by Logi Analytics.

article thumbnail

Antibody Drug Conjugates Keep Growing: What You Need to Know

JD Supra: Mergers

Over the past few years economic headwinds have resulted in fewer deals, with companies and private equity firms alike reassessing where to spend money. As a result, worldwide antibody drug conjugates (ADCs) sales are projected to reach. What Are ADCs and Why Are They Growing? By: Foley & Lardner LLP

article thumbnail

Mid-market M&A Advisory Services in a Changing Economic Landscape with Steve Conwell

How2Exit

b' E185: Mid-market M&A Advisory Services in a Changing Economic Landscape with Steve Conwell - Watch Here rn rn About the Guest(s): rn Steve Conwell is a co-founder of Final Ascent, a mid-market M&A advisory firm specializing in exit planning and succession strategies.

M&A 130